News

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...
The results showed country-specific challenges, such as elevated OTA in southern Europe and FUM across Latin America and ...
Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...
Nonpharmacologic treatments, such as cognitive behavioral therapy, help reduce sleep disorders in patients with multiple sclerosis.
Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.
There is some promising research, but at this time, there doesn't appear to be an effective method of multiple sclerosis prevention. Here's what research has found so far.
Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...
Autoimmune diseases, like multiple sclerosis result when the body’s immune system starts to attack its own cells. Regulatory ...
Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively disabling disease of unknown cause. The first pathological descriptions of the disease ...
In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...